Surrozen : Szn-043 Clinical Trial Program in Severe Alcohol-Associated Hepatitis & Anticipate That Proof-of-Concept Data May Be Available in H1 2025
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.